CN87103568A - 与htlv-iii病毒有关的肽，上述肽的抗体、疫苗、爱滋病病毒的被动和主动免疫以及爱滋病病毒血清检测的诊断试验 - Google Patents

与htlv-iii病毒有关的肽，上述肽的抗体、疫苗、爱滋病病毒的被动和主动免疫以及爱滋病病毒血清检测的诊断试验 Download PDF

Info

Publication number
CN87103568A
CN87103568A CN198787103568A CN87103568A CN87103568A CN 87103568 A CN87103568 A CN 87103568A CN 198787103568 A CN198787103568 A CN 198787103568A CN 87103568 A CN87103568 A CN 87103568A CN 87103568 A CN87103568 A CN 87103568A
Authority
CN
China
Prior art keywords
lys
glu
antibody
peptide
aids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN198787103568A
Other languages
English (en)
Chinese (zh)
Inventor
阿兰
L·戈尔茨坦
王苏三
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Viral Technologies Inc (us) 777 14th Street Nw Washington Dc 20005 Us
Original Assignee
Viral Technologies Inc (us) 777 14th Street Nw Washington Dc 20005 Us
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viral Technologies Inc (us) 777 14th Street Nw Washington Dc 20005 Us filed Critical Viral Technologies Inc (us) 777 14th Street Nw Washington Dc 20005 Us
Publication of CN87103568A publication Critical patent/CN87103568A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1143—Gag-pol proteins, e.g. p17or p24
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/14011—Deltaretrovirus, e.g. bovine leukeamia virus
    • C12N2740/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
    • C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • AIDS & HIV (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Endocrinology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN198787103568A 1986-05-19 1987-05-18 与htlv-iii病毒有关的肽，上述肽的抗体、疫苗、爱滋病病毒的被动和主动免疫以及爱滋病病毒血清检测的诊断试验 Pending CN87103568A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86459986A 1986-05-19 1986-05-19
US864599 1986-05-19

Publications (1)

Publication Number Publication Date
CN87103568A true CN87103568A (zh) 1988-01-27

Family

ID=25343634

Family Applications (1)

Application Number Title Priority Date Filing Date
CN198787103568A Pending CN87103568A (zh) 1986-05-19 1987-05-18 与htlv-iii病毒有关的肽，上述肽的抗体、疫苗、爱滋病病毒的被动和主动免疫以及爱滋病病毒血清检测的诊断试验

Country Status (17)

Country Link
EP (1) EP0246829B1 (2)
JP (3) JPH089636B2 (2)
KR (1) KR910002690B1 (2)
CN (1) CN87103568A (2)
AT (1) ATE100469T1 (2)
AU (1) AU606595B2 (2)
DE (1) DE3788822T2 (2)
DK (1) DK173040B1 (2)
ES (1) ES2061495T3 (2)
GB (1) GB2190679B (2)
IE (1) IE60274B1 (2)
IL (1) IL82471A (2)
IN (1) IN167198B (2)
MX (1) MX167236B (2)
NZ (1) NZ220200A (2)
PH (1) PH26239A (2)
ZA (1) ZA873215B (2)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1219232A (en) * 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
US4863730A (en) * 1986-03-21 1989-09-05 Cenfold Holdings, S.A. Immunotherapy for AIDS patients
DE346022T1 (de) * 1988-06-10 1990-05-23 Medical Research Council, London Peptidfragmente von hiv.
US5219725A (en) 1988-12-05 1993-06-15 Idexx Laboratories Incorporated Monoclonal antibodies to feline-t-lymphotropic lentivirus
DE69008712T2 (de) * 1989-02-01 1994-10-13 Du Pont Hiv p17-test für die überwachung des verlaufs von aids.
JP3058685B2 (ja) * 1989-05-08 2000-07-04 アイデックス ラボラトリーズ インコーポレーテッド ネコｔ細胞リンパトロピック レンチウィルスのポリペプチド
NZ235538A (en) * 1989-10-12 1992-06-25 Viral Technologies Inc Peptides immunoreactive with antibodies to hiv p17; carrier-bound peptides, vaccines, immunoassay and a method for forming antibody enriched sera
DE4106686A1 (de) * 1991-03-02 1992-09-03 Daimler Benz Ag Verriegelungsanordnung
FR2734281B1 (fr) * 1995-05-18 1997-07-25 Commissariat Energie Atomique Fragments d'acide nucleique derives du genome du virus vih-1, peptides correspondants et leurs applications en tant que reactifs d'evaluation du risque de transmission materno-foetale du vih-1
US6093400A (en) * 1996-08-09 2000-07-25 Cel Sci Corporation Modified HGP-30 peptides, conjugates, compositions and methods of use
CA2262432A1 (en) 1996-08-09 1998-02-19 Viral Technologies, Inc. Hiv p-17 peptide fragment, compositions containing and methods for producing and using same
US6818392B2 (en) 2000-12-06 2004-11-16 Abbott Laboratories Monoclonal antibodies to human immunodeficiency virus and uses thereof
EP1217719B1 (en) 2000-12-21 2010-11-17 Semiconductor Components Industries, LLC Method and apparatus for reducing audible noise in a power supply transformer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4264571A (en) * 1979-01-22 1981-04-28 George Washington University Radioimmunoassay of thymosin α1
DE2919592A1 (de) * 1979-05-15 1981-01-15 Max Planck Gesellschaft Verfahren zur herstellung von thymosin- alpha 1 und derivaten davon
US4339427A (en) * 1980-04-14 1982-07-13 Hoffmann-La Roche Inc. Radioimmunoassay of thymosinα
US4517119A (en) * 1983-04-04 1985-05-14 Hoffmann-La Roche Inc. Synthesis of thymosin α1
US4504415A (en) * 1983-04-04 1985-03-12 Hoffman-La Roche Inc. Synthesis of thymosin α1 and desacetyl thymosin α1

Also Published As

Publication number Publication date
IL82471A (en) 1993-02-21
DK245287A (da) 1987-11-20
NZ220200A (en) 1990-08-28
GB2190679B (en) 1991-02-20
KR910002690B1 (ko) 1991-05-03
AU606595B2 (en) 1991-02-14
IE60274B1 (en) 1994-06-29
IE871289L (en) 1987-11-19
JPH0925300A (ja) 1997-01-28
EP0246829A3 (en) 1989-08-09
IN167198B (2) 1990-09-15
DE3788822T2 (de) 1994-07-28
DE3788822D1 (de) 1994-03-03
GB2190679A (en) 1987-11-25
JP2598245B2 (ja) 1997-04-09
ES2061495T3 (es) 1994-12-16
JPH089636B2 (ja) 1996-01-31
PH26239A (en) 1992-04-01
JPS6327498A (ja) 1988-02-05
DK173040B1 (da) 1999-11-29
ATE100469T1 (de) 1994-02-15
JPH083200A (ja) 1996-01-09
DK245287D0 (da) 1987-05-14
ZA873215B (en) 1987-10-28
KR870011154A (ko) 1987-12-21
EP0246829B1 (en) 1994-01-19
AU7313587A (en) 1987-11-26
MX167236B (es) 1993-03-11
EP0246829A2 (en) 1987-11-25
IL82471A0 (en) 1987-11-30
GB8711567D0 (en) 1987-06-17

Similar Documents

Publication Publication Date Title
US4983387A (en) HIV related peptides, immunogenic antigens, and use therefor as subunit vaccine for AIDS virus
EP0231914B1 (en) HTLV-III envelope peptides
AU7234387A (en) Synthetic htlv-iii peptides, compositions and uses thereof
EP0246829B1 (en) HTLV-III virus related peptides, antibodies to the peptides, vaccines, passive and active immunization against AIDS virus and diagnostic test for the serological detection of the AIDS virus
AU664828B2 (en) Synthetic peptides and mixtures thereof for detecting HIV antibodies
EP0326490B1 (en) Synthetic peptides and mixtures thereof for detecting HIV antibodies
US5003043A (en) Peptides representing epitopic sites for the major HTLV-I envelope protein, antibodies thereto, and uses thereof
EP0426314B1 (en) HIV related peptides
EP0498905A1 (en) Conformational epitopes of human immunodeficiency virus envelope glycoprotein gp120
CA1341594C (en) Synthetic peptides and mixtures therof for detecting hiv antibodies
JPH0326347B2 (2)

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C01 Deemed withdrawal of patent application (patent law 1993)
WD01 Invention patent application deemed withdrawn after publication